These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7418113)

  • 1. Protein binding of sulfonamides and displacing effects of sulfinpyrazone on the bound sulfonamides in nephrotic patients in the remissive stage.
    Kawamura T; Yagi N; Yamahata K; Ohnishi M; Kadowaki J; Takada M
    Chem Pharm Bull (Tokyo); 1980; 28(4):1331-6. PubMed ID: 7418113
    [No Abstract]   [Full Text] [Related]  

  • 2. Transformation and excretion of drugs in biological systems. IX. Interactions between sulfinpyrazone and sulfonamides, and between oxyphenbutazone and sulfonamides in dogs.
    Takada M; Misawa A; Fujimoto K; Hori R; Arita T
    Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):551-9. PubMed ID: 4424155
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.
    Anton AH
    Ann N Y Acad Sci; 1973 Nov; 226():273-92. PubMed ID: 4588442
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and biophysical behaviors of plasma albumin. II. Comparison of plasma albumin from normal subjects and nephrotic patients.
    Ito M; Yamahata K; Yagi N; Sakamoto M; Sekikawa H; kadowaki J; Ohnishi M; Itoh H; Takada M
    J Pharmacobiodyn; 1981 Nov; 4(11):901-6. PubMed ID: 7328492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALTERATION OF THE ACETYLATION OF SULFONAMIDES BY PROTEIN BINDING, SULFINPYRAZONE, AND SURAMIN.
    ANTON AH; BOYLE JJ
    Can J Physiol Pharmacol; 1964 Nov; 42():809-17. PubMed ID: 14324214
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the comparative drug binding to intra- (liver fatty acid binding protein) and extra- (human serum albumin) cellular proteins.
    Rowland A; Hallifax D; Nussio MR; Shapter JG; Mackenzie PI; Brian Houston J; Knights KM; Miners JO
    Xenobiotica; 2015; 45(10):847-57. PubMed ID: 25801059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced change in the distribution of sulfonamides in the mother rat and its fetus.
    Anton AH; Rodriguez RE
    Science; 1973 Jun; 180(4089):974-6. PubMed ID: 4706687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interindividual differences in the protein binding of sulfonamides: the effect of disease and drugs.
    Anton AH; Corey WT
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():134-51. PubMed ID: 5316395
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone.
    Toon S; Trager WF
    J Pharm Sci; 1984 Nov; 73(11):1671-3. PubMed ID: 6520783
    [No Abstract]   [Full Text] [Related]  

  • 10. Competition between sulfonamides and tetracyclines in the binding with serum proteins.
    Genazzani E; Bononi LJ; Pagnini G; DiCarlo R
    Antimicrob Agents Chemother (Bethesda); 1965; 5():192-6. PubMed ID: 5883425
    [No Abstract]   [Full Text] [Related]  

  • 11. Albumin distribution in the nephrotic rat.
    Sellers AL; Katz J; Bonorris G
    J Lab Clin Med; 1968 Mar; 71(3):511-6. PubMed ID: 5645889
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of tissue fluid and plasma concentrations of a protein-bound drug sulphormethoxine by in vivo dialysis in rats.
    McQueen EG
    Br J Pharmacol Chemother; 1968 Jun; 33(2):312-8. PubMed ID: 5664151
    [No Abstract]   [Full Text] [Related]  

  • 13. Anabolic agents in kidney disease: the effect of formebolone on protein synthesis in patients with renal insufficiency or nephrosis.
    Esposito R; Pluvio M; Giordano D
    Curr Med Res Opin; 1975; 3(1):43-5. PubMed ID: 1116383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the serum protein binding and renal elimination of isomeric sulfonamides (5-sulfanilamide-3-ethyl-1,2,4-thiodiazol and 5-sulfanilamido-2-ethyl-1,3,4-thiodiazol)].
    Irmscher K; Gabe D; Jahnke K; Scholtan W
    Arzneimittelforschung; 1966 Aug; 16(8):1019-25. PubMed ID: 6014883
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of aspirin on the pharmacokinetics of sulfinpyrazone in man.
    Buchanan MR; Endrenyi L; Giles AR; Rosenfeld J
    Thromb Res Suppl; 1983; 4():145-52. PubMed ID: 6579708
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of salicylate on the binding of sulfonamides to bovine serum albumin.
    Higashi Y; Nishihata T; Kubo K; Yata N; Kamada A
    Chem Pharm Bull (Tokyo); 1978 Nov; 26(11):3572-6. PubMed ID: 729128
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of simultaneous administration of drugs on absorption and excretion. VIII. Effect of plasma-protein binding displacement on the intestinal absorption of sulfonamides in rabbits.
    Imamura Y; Ichibagase H
    Chem Pharm Bull (Tokyo); 1977 Dec; 25(12):3400-5. PubMed ID: 608228
    [No Abstract]   [Full Text] [Related]  

  • 18. Albumin catabolism in hypoproteinaemic states studies with 131-I-albumin.
    Freeman T; Gordon AH
    Bibl Haematol; 1965; 23():1108-15. PubMed ID: 5894593
    [No Abstract]   [Full Text] [Related]  

  • 19. [Theoretical research on the interaction between drugs and receptor models. VIII. An interaction model for the binding of sulfonamides on human serum albumin].
    Höltje HD; Adler P
    Arch Pharm (Weinheim); 1987 Mar; 320(3):234-40. PubMed ID: 3579525
    [No Abstract]   [Full Text] [Related]  

  • 20. FATTY LIVER IN PREDNISOLONE TREATED NEPHROTIC CHILDREN.
    BHAKOO ON; WALIA BN
    J Trop Pediatr Afr Child Health; 1963 Dec; 9():74-80. PubMed ID: 14088989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.